000			02161cam a2200313 a 4500
003			EG-GiCUC
008			160204s2015 ua h f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aM.Sc
099			_aCai01.11.31.M.Sc.2015.Li.V
100	0		_aLiza Omer Salem Daiban
245	1	4	_aThe value of dynamic contrast-enhanced mri in the diagnosis and management of triple negative breast cancer / _cLiza Omer Salem Daiban ; Supervised Rasha Mohammed Kamal , Heba Allah Mounir Azzam
246	1	5	_aقيمة التصوير بالرنين المغناطيسي الديناميكي بالصبغة في تشخيص وعلاج سرطان الثدي السلبي الثلاثي
260			_aCairo : _bLiza Omer Salem Daiban , _c2015
300			_a225 P. : _bfacsimiles ; _c25cm
502			_aThesis (M.Sc.) - Cairo University - Faculty of Medicine- Department of Radio-diagnosis
520			_aBreast cancer (BC) is by far the world{u2019}s most common cancer among women, and it is the most common cause of cancer related death in women worldwide. Triple negative breast cancer (TNBC) is a subtype of breast cancer that lacks expression of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor 2 (HER2). TNBC is characterized by distinct clinical, pathological features and don't respond to endocrinal therapy or targeted agents .Imaging for TNBC represents a diagnostic challenge to breast radiologists, and the aim of this work is to assess the MRI features of TNBC in comparison to other breast cancer subtypes and to validate its impact on management. Contrast-enhanced MRI is an accurate assessment of tumor response after Neo-Adjuvant Chemotherapy and should be incorporated in the evaluation of all patients with TNBC
530			_aIssued also as CD
653		4	_aDynamic Contrast-Enhanced MRI
653		4	_aTNBC
653		4	_aTriple Negative Breast Cancer
700	0		_aHeba Allah Mounir Azzam , _eSupervisor
700	0		_aRasha Mohammed Kamal , _eSupervisor
905			_aAml _eCataloger
905			_aNazla _eRevisor
942			_2ddc _cTH
999			_c54925 _d54925